tradingkey.logo
tradingkey.logo
Search

Nanovibronix Inc

NAOV
Add to Watchlist
4.020USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
3.17MMarket Cap
LossP/E TTM

More Details of Nanovibronix Inc Company

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Nanovibronix Inc Info

Ticker SymbolNAOV
Company nameNanovibronix Inc
IPO dateApr 24, 2015
CEOBesser (Doron)
Number of employees15
Security typeOrdinary Share
Fiscal year-endApr 24
Address969 Pruitt Piace
CityTYLER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75703
Phone19142333004
Websitehttps://nanovibronix.com/
Ticker SymbolNAOV
IPO dateApr 24, 2015
CEOBesser (Doron)

Company Executives of Nanovibronix Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Nanovibronix Inc?

The top five shareholders of Nanovibronix Inc are: Dr. Harold Jacob, M.D.

How many institutions hold shares of Nanovibronix Inc (NAOV)?

As of 2026Q1, 17 institutions hold shares of Nanovibronix Inc, with a combined market value of approximately 44.60K, accounting for 1.21% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 33009.00.